Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · LAXMIDENTL

LAXMIDENTL

HealthcareHealthcare Equipment & Supplies₹1075 cr market cap
₹193.00 ▼ -1.22% today As of 19 Nov 2026
52-week low ₹158.2552-week high ₹321.35

-39.2% from the 52-week high · +23.5% above the low

Laxmi Dental Ltd manufactures and supplies dental equipment, instruments, and oral healthcare products. The company serves dental clinics, hospitals, and educational institutions, combining innovation with quality manufacturing processes. It maintains a reputation for reliability and durability in dental solutions.

The short version. LAXMIDENTL reported revenue of ₹80 crore for Sep 2026, up 11.1% from a year earlier. Net profit was ₹10 crore (up 11.1% year on year). Return on equity was 11.9% in Mar 2026. Promoter holding was 41.75% in Sep 2026, up 0.05 points over 8 quarters.

1 · The price

How has the stock traded?

LAXMIDENTL trades 39.2% below its 52-week high and 23.5% above its 52-week low.

Change over period: —

1M+7.5%
3M-0.2%
6M-3.8%
1Y-35.6%

2 · The business

Is it growing?

Sales, year on year+11.1%

Sep 2026 revenue of ₹80 cr.

Profit, year on year+11.1%

Sep 2026 net profit of ₹10 cr.

Net margin12.6%

0.8 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue8075746672666162
Net profit10101029845
Net margin %12.613.813.63.011.812.87.17.8
EPS (₹)1.821.871.830.361.551.530.780.87

Annual

FY2026FY2025
Revenue278239
Net profit2932
Net margin %10.413.3
EPS (₹)5.275.78

3 · The quality

How well does it turn capital into profit?

Return on equity was 11.9% in Mar 2026; debt to equity is 0.00.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %11.915.2
Return on capital %11.516.3
EBITDA margin %16.121.6
Net margin %10.113.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.00
Interest cover22.2x
Current ratio6.21
P/E ratio33.9

4 · The owners

Who holds it, and are they adding?

Promoter holding41.75%

Up 0.05 pts over 8 quarters.

Foreign institutions6.58%

Down 22.91 pts over 8 quarters.

Domestic institutions10.68%

Down 4.5 pts over 8 quarters.

Mutual fund schemes15

+6 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter41.741.741.741.741.741.7741.841.75+0.05
FII29.4934.2433.5932.3932.4531.2130.16.58-22.91
DII15.1812.8614.3111.8510.8310.5210.8910.68-4.5
Public13.6311.1910.414.0615.0216.517.2141.0+27.37

Mutual fund holdings · Oct 2026

15 schemes hold this stock

9 the month before.

  • UTI - Healthcare Fund1.14% of NAV
  • ICICI Prudential Healthcare Fund0.62% of NAV
  • HDFC Pharma and Healthcare Fund0.31% of NAV
  • WhiteOak Capital Pharma and Healthcare Fund0.29% of NAV
  • Bank Of India SMALL CAP FUND0.22% of NAV
  • HDFC Consumption Fund0.21% of NAV
  • DSP Healthcare Fund0.13% of NAV
  • TATA ELSS - TAX SAVER FUND0.12% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for LAXMIDENTL are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about LAXMIDENTL

What is the LAXMIDENTL share price?

LAXMIDENTL (LAXMIDENTL) last closed at ₹193.00, down 1.22% on the day. Its 52-week range is ₹158.25 to ₹321.35.

What is the market cap of LAXMIDENTL?

LAXMIDENTL has a market capitalisation of about ₹1,075 crore. Its price-to-earnings ratio is 33.9.

How are LAXMIDENTL's latest results?

LAXMIDENTL reported revenue of ₹80 crore for Sep 2026, up 11.1% from a year earlier. Net profit was ₹10 crore (up 11.1% year on year). Return on equity was 11.9% in Mar 2026. Promoter holding was 41.75% in Sep 2026, up 0.05 points over 8 quarters.

Who owns LAXMIDENTL?

As of Sep 2026, shareholding was: Promoter 41.75%, FII 6.58%, DII 10.68%, Public 41.0%.

How many mutual funds hold LAXMIDENTL?

15 mutual fund schemes held LAXMIDENTL in October 2026. That compares with 9 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.